Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70599 ↗Kurz gefasst
Klinische Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Hiromasa Fujita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cytology Center of Hokkaido Cancer Society, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Early Detection of Cancer, Ovarian Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Ovarian Epithelial. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Early detection of ovarian cancer at stage I is important to improve patients‘ prognosis. The goal of this study was to examine if transvaginal ultrasound (TVU) performed at the same time as cervical cancer screening can facilitate early detection of ovarian cancer.
Methods
From 2014 to 2022, 483 269 women underwent TVU examinations during cervical cancer screening. The criteria for abnormal findings on TVU were ovarian enlargement ≥3 cm in long diameter (≥2 cm in postmenopausal women).
Results
Of the 483 269 women who underwent TVU, 3294 (0.68%) were selected for detailed examination. Of these women, 550 underwent surgery and 80 cases of ovarian cancer were found (positive predictive value: 2.43%). Pathologic review in 76 of these cases showed 70 cases of epithelial ovarian cancer (type I: 54 [77.1%], Type II: 16 [22.9%]) and six cases of non‐epithelial malignant tumors. Clinical staging analysis showed that 81.6% (62 cases) were at stage I. Significantly more type I than type II tumors were detected at stage I (87.3% ( n = 46) vs. 56.3%, P = 0.0068 ( n = 9)). Notably, 95.7% (22/23) of clear cell carcinoma cases were detected at stage I.
Discussion
The high rate of early detection of type I ovarian cancer might be due to its slow progression. In Asia, where type I is common, the benefits of screening for ovarian cancer are particularly great. However, screening with TVU has generally been considered to have little benefit. The results of this study suggest a need for reassessment of this view.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cytology Center of Hokkaido Cancer Society, Sapporo, Hokkaido, Japan.
- Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
- Ozawa Women's General Clinic, Senndai, Miyagiken, Japan.
- Cancer Center, Shin-Yurigaoka General Hospital, Kawasaki, Kanagawaken, Japan.
ORCID-Profile: Hiromasa Fujita
Zitieren
APA
Fujita, H., Okamoto, K., Kato, H., Watari, H., Ozawa, N., & Suzuki, M. (2025). Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70599
Vancouver
Fujita H, Okamoto K, Kato H, Watari H, Ozawa N, Suzuki M. Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70599
BibTeX
@article{Fujita2025,
author = {Fujita, Hiromasa and Okamoto, Kazuhira and Kato, Hidenori and Watari, Hidemichi and Ozawa, Nobuyoshi and Suzuki, Mitsuaki},
title = {Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70599}
}
EUVIMED